Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Fox, MD
Division of Rheumatology - University of Michigan Health System
Study Chair - Yang Mao-Draayer, MD, PhD
Multiple Sclerosis Center - University of Michigan Health System
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Jordan Research & Education Institute: Sutter Alta Bates Summit
Berkeley, California, United States
- University of Southern California
Los Angeles, California, United States
- University of California, Davis
Sacramento, California, United States
- University of Colorado
Aurora, Colorado, United States
- University of Michigan Health System -Multiple Sclerosis Center
Ann Arbor, Michigan, United States
- Henry Ford Health System
Detroit, Michigan, United States
- Minneapolis Clinic of Neurology
Golden Valley, Minnesota, United States
- University of New Mexico: Health Sciences Center
Albuquerque, New Mexico, United States
- South Shore Neurologic Associates - Multiple Sclerosis Care Center
Patchogue, New York, United States
- Carolinas Medical Center (cmc)
Charlotte, North Carolina, United States
- Cleveland Clinic: Mellen Center for Multiple Sclerosis
Cleveland, Ohio, United States
- Providence Multiple Sclerosis Center
Portland, Oregon, United States
- Swedish Neuroscience Institute
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2014
- Primary completion
- 12 Jul 2017
- Completion
- 12 Jul 2017
- Last update posted
- 9 Nov 2020
- Registered enrollment
- 36
- Registry id
- NCT02330965
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.